Skip to main content
Important Update Actualización importante:

Good news! All CHIP, STAR, and STAR Kids Member Handbooks are now available online. Quick, easy access to your benefits and coverage information - any time!

¡Buenas noticias! Todos los manuales para miembros de CHIP, STAR y STAR Kids ya están disponibles en línea. Obtén acceso rápido y sencillo a la información sobre tus beneficios y cobertura, ¡en cualquier momento!

Medicaid Preferred Drug List and Formulary Changes Cambios en el formulario y la lista de medicamentos preferidos de Medicaid

The Vendor Drug Program (VDP) made changes to the Texas Medicaid drug formulary effective July 24, 2026. To learn more about formulary changes impacted, please click here for more information.

El programa de medicamentos de proveedores de Texas (VDP) ha realizado cambios recientes en el formulario de medicamentos de Medicaid de Texas. Esto entrará en vigencia el 24 de julio de 2026. Para obtener más información sobre los cambios en el formulario afectados, visite el siguiente enlace para obtener más información.

Clinical Prior Authorization Criteria Updates

Date: December 16, 2024

Attention: Providers

Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that the Texas Health and Human Services (HHSC) has updated multiple clinical prior authorization criteria guides. 

How this impacts providers: HHSC reviewed the following clinical prior authorization criteria guides and made updates. The list of revisions is on available on Navitus page.

The following drug categories are impacted:

  • ADD/ADHD
  • Aliskiren-Containing Agents
  • Antimigraine-Triptans
  • Appetite Suppressant Agents
  • Buprenorphine Agents
  • CGRP Antagonists, Prophylaxis
  • CNS Stimulants
  • Cortisol Receptor Antagonists
  • Cytokine and CAM Antagonists
  • Diclofenac Topical
  • DDP-4 Inhibitors
  • Duplicate Therapy
  • Erthropoiesis-Stimulating Factors
  • Evrysdi
  • Fentanyl Agents
  • Gabapentin Agents
  • GI Motility Agents
  • Growth Hormone Agents
  • HP Acthar
  • Immunomodulator Agents for Dry Eye
  • Inhaled Antibiotics
  • Lupus Agents
  • Monoclonal Antibody Agents
  • Opiate Overutilization
  • Opiate/Benzodiazepine/Muscle Relaxant Combinations
  • Oxycodone Extended-Release Agent
  • Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors
  • Voxogo

Next step for Providers: Providers should visit the Navitus page to become familiar with the changes and share this information with their staff. 

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts: https://www.texaschildrenshealthplan.org/provideralerts